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Abstract
Background—The molecular changes that occur in the stomach that are associated with 
idiopathic gastroparesis are poorly described. The aim of this study was to use quantitative 
analysis of mRNA expression to identify changes in mRNAs encoding proteins required for the 
normal motility functions of the stomach.
Methods—Full thickness stomach biopsy samples were collected from non-diabetic control 
subjects that exhibited no symptoms of gastroparesis and from patients with idiopathic 
gastroparesis. mRNA was isolated from the muscularis externa and mRNA expression levels were 
determined by quantitative reverse transcriptase (RT)-PCR.
Key Results—Smooth muscle tissue from idiopathic gastroparesis patients had decreased 
expression of mRNAs encoding several contractile proteins, such as MYH11 and MYLK1. 
Conversely, there was no significant change in mRNAs characteristic of interstitial cells of Cajal 
(ICCs) such as KIT or ANO1. There was also a significant decrease in mRNA encoding platelet 
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derived growth factor receptor α (PDGFRα) and its ligand PDGFB and in Heme oxygenase 1 in 
idiopathic gastroparesis subjects. In contrast, there was a small increase in mRNAs characteristic 
of neurons. Although there was not an overall change in KIT expression in gastroparesis patients, 
KIT expression showed a significant correlation with gastric emptying whereas changes in 
MYLK1, ANO1 and PDGFRα showed weak correlations to the fullness/satiety subscore of 
patient assessment of upper gastrointestinal disorders-symptom severity index scores.
Conclusions and Inferences—Our findings suggest that idiopathic gastroparesis is associated 
with altered smooth muscle cell contractile protein expression and loss of PDGFRα+ cells without 
a significant change in ICCs.
Abbreviated abstract
qRT-PCR analysis revealed that smooth muscle tissue from idiopathic gastroparesis patients had 
decreased expression of mRNAs encoding several contractile and regulatory proteins, 
PDGFRalpha and its ligand PDGFB and Heme oxygenase 1. Conversely, there was no significant 
change in mRNAs characteristic of interstitial cells of Cajal (ICCs), such as KIT or ANO1. These 
findings suggest that idiopathic gastroparesis is most commonly associated with transcriptional 
changes that are indicative of altered smooth muscle cells and PDGFRalpha positive fibroblast 
cells rather than ICCs.
Keywords
gastroparesis; interstitial cells of Cajal; smooth muscle; fibroblasts; neurons; macrophages; 
transcription
Introduction
Gastroparesis defined as delayed gastric emptying in the absence of a physical obstruction, 
is estimated to occur in about 1.8% of the adult population, with the majority of cases being 
in women.1, 2 Patients with gastroparesis have a marked decrease in their quality of life, with 
symptoms including nausea, vomiting, early satiety, bloating and abdominal pain. Treatment 
of gastroparesis is difficult as there are usually multiple symptoms to treat and the symptoms 
do not accurately reflect the underlying pathophysiology. Treatment of gastroparesis is 
further hampered by the lack of understanding of the underlying molecular changes that 
cause or contribute to the disease pathology. Of patients with gastroparesis approximately 
36% are idiopathic 29% diabetic and 13% postsurgical.3, 4 As gastric emptying is dependent 
on an intricate interaction of neural cells, interstitial cells of Cajal (ICC), platelet derived 
growth factor α positive (PDGFRα+) fibroblasts and smooth muscle cells (SMCs), it is 
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likely that defects in any of these cell types can contribute to this disease.5–10 ICC are the 
pacemaker cells in the stomach that transmit slow wave depolarization to the gastric smooth 
muscle cells.7, 11 The PDGFRα+ fibroblasts are a more recently recognized component of 
the electrical syncytium that controls gastric contractility. These cells transmit inhibitory 
neural signals to gastric smooth muscle cells.5 The major goal of our study was to use 
transcriptional profiling to identify changes in any of these cell types that may be associated 
with idiopathic gastroparesis.
Histopathological analyses have suggested decreases in numbers of ICCs and increases in 
numbers of CD45 and CD68 positive blood cells in gastric body biopsies from diabetic and 
idiopathic gastroparesis patients.12 A similar decrease in ICCs has been observed in mouse 
models of diabetes.13 In contrast, it has been reported that there are no changes in the 
PDGFRα+ cell number in either group of gastroparesis patients.6 It has also been proposed 
that an increased ratio of M1 relative to M2 macrophages may contribute to delayed gastric 
emptying in diabetic gastroparesis.14 In the previous human studies ICCs have been 
identified by their immunoreactivity with anti-KIT antibodies (CD117). KIT is a receptor 
tyrosine kinase found on the surface of ICC that is required for ICC survival and 
proliferation.12 Mouse models have suggested that diabetes-induced loss of ICC may result, 
at least in part, from decreased expression of KIT ligand (KITLG or Stem Cell Factor) from 
atrophied gastric SMCs.15 It is not clear if similar changes occur in humans with either 
diabetic or idiopathic gastroparesis.
All the previous human studies have relied on histological analyses, there have been no 
definitive quantitative studies that have identified molecular changes that could initiate or 
contribute to the dysmotility observed in patients with gastroparesis. The goal of the current 
study was to begin to address this gap in our knowledge by using real time RT-PCR to 
quantitate changes in mRNA expression that occur within the muscularis layer of the 
stomach of patients with idiopathic gastroparesis.
Materials and Methods
Clinical Assessment
All procedures were conducted under protocol approved by the Indiana University 
Institutional Review Board. Informed consents were obtained from control subjects and 
patients with idiopathic gastroparesis. Idiopathic gastroparesis was defined as patients with 
symptoms of gastroparesis ≥ 3 months with delayed gastric emptying by 4-hour gastric 
scintigraphy or gastric bezoar with undigested foods by upper endoscopy after an overnight 
fast. Gastric scintigraphy was performed following consumption of a low fat egg-white meal 
with imaging at 0, 2 and 4hrs as described previously.16, 17 Abnormal gastric emptying was 
defined as 2-hour retention ≥60% or 4-hour retention ≥10%. Symptom presentation was 
classified as vomiting-predominant, dyspepsia-predominant, or regurgitation-predominant, 
based on a clinical classification we previous reported.18 The Patient Assessment of 
Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) was administered.19 
PAGI-SYM is a 20-item severity scale from 0 (none) to 5 (very severe) with six subscales: 
nausea/vomiting, postprandial fullness/early satiety, bloating, heartburn/regurgitation, upper 
abdominal pain, and lower abdominal pain. The Gastroparesis Cardinal Symptom Index 
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(GCSI) was defined as the average of the nausea/vomiting, postprandial fullness/early satiety 
and bloating PAGI-SYM subscale scores.20 Clinical severity were defined using a 
classification suggested by the Gastroparesis Clinical Research Consortium: grade 1, mild 
(symptoms relatively easily controlled and able to maintain weight and nutrition on a regular 
diet); grade 2, compensated (moderate symptoms with only partial control with use of daily 
medications, able to maintain nutrition with dietary adjustments); grade 3, gastric failure 
(refractory symptoms that are not controlled, with the patient having emergency department 
visits, frequent physician visits, or hospitalizations and/or inability to maintain nutrition via 
the oral route).3 Gastroparesis patients included in the study did not have diabetes as 
determined by normal fasting glucose or normal hemoglobin A1c (HbA1c) by blood test. 
We also excluded subjects with other systemic diseases such as surgery with vagal trauma, 
scleroderma, mixed connective tissue disorder and paraneoplastic syndrome.
Full-thickness stomach biopsies
Biopsies from the control group were obtained from non-diabetic individuals without 
gastroparesis symptoms that were undergoing bariatric weight loss surgery (normal HbA1c 
level < 1 month prior to surgery). Control and gastroparesis subjects were age and sex 
matched (Table 1). Surgical full-thickness biopsies from the idiopathic gastroparesis patients 
were obtained at the time of routine pathological analysis in patients with severe symptoms 
or at the time of gastric stimulator placement. In each case (control and gastroparesis 
patients), the biopsy was taken about 10cm from the pylorus on the anterior aspect midway 
between the greater and lesser curvatures of the stomach. All biopsies were obtained using 
linear cutting staplers. For sleeve gastrectomy subjects the sample was obtained after the 
stomach was removed from the abdomen, for all other subjects the samples were obtained 
laparoscopically. Tissues were collected into ice cold DMEM (Dullbeco’s modified eagle 
media) or RNAlater (Ambion) and immediately transferred to the investigator’s laboratory. 
Muscle, submucosal and mucosal layers were separated by dissection, flash frozen in liquid 
nitrogen and ground to a powder under liquid nitrogen prior to storage at −80°. A small 
amount of frozen muscle tissue powder (~150mg) was homogenized in Trizol (Invitrogen) 
and a Purelink Micro RNA isolation kit was used to isolate total RNA. Contaminating DNA 
was removed by on-column DNase treatment. The integrity and purity of the isolated RNA 
was determined using an Agilent Bioanalyzer. Samples used had an RNA integrity number 
of >7.
qRT-PCR
500ng of RNA was used in reverse transcription reactions (High Capacity RT-cDNA Kit, 
Life Technologies). Real time PCR was performed using Syber Green (Roche). Levels of 
mRNA expression were normalized to expression of TATA binding protein (TBP) as an 
internal control and are expressed relative to the mean values seen in samples from control 
patients. The primers used for qRT-PCR are listed in Supplemental Table 1. These primers 
detect mRNAs for the following smooth muscle-specific markers: MYH11 (smooth muscle 
myosin heavy chain), ACTA2 (smooth muscle α-actin), ACTG2 (smooth muscle γ-actin) 
and CCN1 (calponin).21; In addition primers used to detect mRNAs for ATPA4 (which 
encodes the H+/K+ pump) and GAST (gastrin) were used as markers of parietal and G cells, 
respectively, within the mucosa.22 Primers to detect mRNAs for TH (tyrosine hydroxylase), 
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SLC18A2 (VMAT2, a monoamine transporter), VIP (vasoactive intestinal peptide), CHAT 
(choline O-acetyltransferase) and SLC18A3 (solute carrier protein 18A3, which transports 
acetyl choline into secretory vesicles) and UCHL1 (PGP9.5, ubiquitin carboxylterminal 
esterase L1) were used as neural markers.23, 24
Isolation and polarization of human macrophages
Whole blood (~8 mL) was collected from consenting healthy donors using Vacutainer CPT 
Mononuclear Cell Preparation Tubes (CPT; BD) containing sodium citrate. Tubes were 
processed according to the manufacturer’s instructions to separate peripheral blood 
mononuclear cells (PBMCs). PBMCs were washed twice in PBS (5 min at 500 × g) at room 
temperature before being resuspended in complete media (RPMI, 10%FBS, 1% penicillin-
streptomycin, and 10 ng mL−1 recombinant human macrophage colony stimulating factor 
(M-CSF; [R&D Systems]). Isolated PBMCs (1x106 mL−1) were plated on 12 well tissue 
culture-treated plates in complete media. Complete media was refreshed every 48 hours. 
After 7 days, adherent M-CSF-derived cells were treated with 100 ng mL−1 
lipopolysaccharide from E. coli 055:B5 (LPS; Sigma) and 5 ng mL−1 recombinant human 
interferon gamma (IFN-γ; R&D Systems) to induce M1 macrophage polarization or with 20 
ng mL−1 recombinant human interleukin 4 (IL-4; R&D Systems) to induce M2 macrophage 
polarization. Cells were harvested and RNA extracted 24 hrs later.
Statistical analysis
Significant differences between the means values of the gastroparesis and control patients 
were determined using a two-tailed, Welch corrected student T-test in order to account for 
potential differences in the variance in values obtained from control and gastroparesis 
subjects. P values <0.05 were considered significant. Correlations between mRNA levels 
and clinical parameters were determined using Spearman correlations. Where significant 
correlations were found, linear regression analysis was performed in order to visualize the 
correlations graphically. For analysis in which we divided the gastroparesis patients into 
symptom predominant groups, one way Anova was performed using a Kruskal-Wallis test 
with a Duns Multiple Comparison post-test.
Results
Control full thickness biopsy samples of the stomach were obtained from 14 patients 
undergoing bariatric weight loss surgery, 5 patients from sleeve gastrectomy and 9 patients 
from Roux-en-Y bypass surgery. None of the 14 controls subjects had diabetes (normal 
HbA1c < 1 month prior to surgery). Patient samples were obtained from 16 patients with 
idiopathic gastroparesis, 6 patients during laparoscopic implantations of gastric electrical 
stimulator, 5 patients during surgical jejunostomy feeding tube placements (1 of these 
patients also had gastric electrical stimulator), and 6 patients during diagnostic laparoscopies 
with clinical intent of full-thickness biopsy of the stomach to look for underlying 
neuromuscular pathologies. None of the patients with gastroparesis had diabetes. The 
average ages of the control and gastroparesis patients were 42.8±7.8 years and 34.6±10.1 
years, respectively. In addition, 11 of 14 (79%) control subjects were female compared to 14 
out of 16 (87%) patients with gastroparesis. Finally, 12 of the 14 control patients were 
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Caucasian and all of the gastroparesis group were Caucasian. Body mass index (BMI) was 
significantly greater in the control subjects (47.8±8.9 compared to 25.1±6.9). The clinical 
characteristics of the 16 patients with idiopathic gastroparesis are provided in Table 1.
Dissected muscle layer is free of contaminating mucosa
To confirm that we effectively separated the muscle, submucosal and mucosal layers during 
dissection we performed a focused quantitative real time reverse transcriptase-PCR (qRT-
PCR) analysis of mRNAs whose expression are expected to be localized to specific cell 
types. This analysis revealed that the muscle layer has high levels of expression of the 
smooth muscle markers and low to undetectable levels of expression of the mucosal 
markers, as expected (Figure 1). In contrast, the mucosal layer has high levels of expression 
of mucosal markers ATPA4 and GAST and very low expression of smooth muscle markers 
(Figure 1). Neuronal markers are most abundant in the muscle and submucosal layers, 
consistent with the presence of the myenteric and submucosal nerve plexi, respectively, in 
these layers (Figure 1). The submucosal layer is rich in blood vessels, which likely accounts 
for the relatively high levels of expression of smooth muscle markers that were also 
observed in this layer, as these proteins would be expected to be expressed in vascular 
SMCs. These data suggest that the dissected muscularis layer is highly enriched with smooth 
muscle cells.
Loss of PDGFRα+ fibroblasts but not ICCs in idiopathic gastroparesis
To determine if idiopathic gastroparesis is associated with loss of ICCs from the muscle 
layer we quantitated expression of mRNAs encoding ICC markers KIT and ANO1 as well as 
the KIT ligand (KITLG). This analysis revealed no significant change in expression of any 
of these markers in samples from idiopathic gastroparesis patients (Figure 2A). Spearman 
correlation analysis revealed a small but significant correlation between KIT and ANO1 
expression levels, which would be expected if these mRNAs are indicative of ICC number 
(Figure 2A). There was also a weak, although significant correlation between ANO1 
expression and KITLG expression, but the correlation between KIT and KITLG expression 
did not reach significance (Figure 2A). In contrast to the lack of changes in ICC markers, we 
observed a significantly decreased expression of mRNAs encoding PDGFRα and its ligands 
PDGFA and PDGFB, suggesting that there may be a loss of the PDGFRα-positive 
(PDGFRα+) fibroblasts (Figure 2B). The expression of PDGFRα mRNA displayed a strong 
positive correlation to PDGFB mRNA levels but no significant correlation to PDGFA 
mRNA levels using a Spearman correlation analysis (Figure 2B).
Attenuated expression of mRNAs encoding some proteins characteristic of differentiated 
contractile SMCs in gastroparesis subjects
To determined if alterations in SMCs may also occur in gastroparesis patients we examined 
expression of mRNAs encoding proteins characteristic of differentiated contractile SMCs. 
This analysis revealed a specific decrease in expression of MYH11, MYLK1 and PAK1 
without any significant change in ACTA2, ACTG2 or CCN1 (Figure 3). Transcription of 
both MYLK1 and MYH11 is known to be dependent on SRF complexes, whose activity can 
be modulated by myocardin.25–27 We thus analyzed the expression of mRNAs encoding 
these proteins and found that the changes in mRNAs encoding contractile proteins were 
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accompanied by significantly decreased expression of SRF but not myocardin transcripts 
(Figure 3). The expression levels of MYLK and MYH11 transcripts were significantly 
correlated with expression of SRF transcripts, across all of our human samples (Figure 4).
Reduced expression of mRNAs encoding anti-inflammatory proteins in gastroparesis 
subjects
To evaluate potential changes in inflammation and macrophage activation in idiopathic 
gastroparesis we examined the expression of mRNAs encoding inflammatory cytokines 
IL1β and TNFα, markers of macrophages, CD68, CD86, MRC1(CD206), HMOX1(HO-1) 
and CLEC7A and anti-inflammatory cytokines such as TGFβ (Figure 5). In order to try to 
distinguish M1 from M2 macrophages, we first examined the relative expression of several 
macrophage markers in human macrophages derived from peripheral blood mononuclear 
cells (PBMCs) from healthy donors. Macrophages were polarized into M1 or M2 
macrophages as described in methods. This analysis identified MRC1, MRC2, HMOX1 and 
CLEC7A as relatively selective markers of M2 macrophages compared to M1 macrophages 
(Supplemental Figure 1). However, each of these markers is also expressed at relatively high 
levels in unstimulated macrophages (M0; Supplemental Figure 1). Of the genes examined, 
only TNFα was selectively expressed by M1 macrophages as compared to M2 macrophages 
(Supplemental Figure 1). Analysis of mRNA isolated from the gastric muscle layer of 
control and gastroparesis subjects did not reveal any significant changes in mRNAs 
encoding proinflammatory cytokines IL1β and TNFα, although we did observe decreased 
expression of the immunosuppressive cytokine TGFβ1 (Figure 5). We also observed 
decreased expression of the pan monocyte/macrophage marker CD68 and decreased 
expression of HMOX1, which encodes heme oxygenase 1 (HO-1), without any significant 
change in other M2 macrophage selective markers, CLEC7A and MRC1 (Figure 5).
Altered expression of mRNAs encoding neural markers in gastroparesis subjects
Previous studies have observed decreases in inhibitory nerves in individual patients with 
gastroparesis, although as a group there was no statistical difference between control and 
gastroparesis patients.12 To evaluate neuronal changes in our samples we assessed levels of 
mRNAs encoding markers of inhibitory nerves, VIP (vasoactive intestinal peptide), NOS1 
(neural nitric oxide synthase), and excitatory nerves, CHAT (choline O-acetyltransferase) 
and SLC18A3 (solute carrier protein 18A3, (VAChT) which transports acetyl choline into 
secretory vesicles)(Figure 6A). This analysis revealed a small but significant increase in 
NOS1 and CHAT mRNA in samples from gastroparesis patients as compared to controls 
(Figure 6A).
Molecular changes correlate with PAGI-SYM subscores
The average percentage of food remaining in the stomachs of our gastroparesis patients 4 
hours after ingestion of a standard low fat egg white meal was 29±19% (Table 1). This large 
variability in gastric emptying allowed us to use Spearman correlation analysis to determine 
if any of the observed molecular changes correlate with impairment of gastric emptying. 
This analysis revealed a significant positive correlation between KIT and delayed gastric 
emptying (Spearman r value of 0.745, Figure 6B) but no correlation between expression of 
ANO1 or markers of PDGFRα+ fibroblasts, SMCs, inflammatory cell or neural markers and 
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gastric retention (P and r values are shown in Supplemental Table 2). Using a similar 
approach we determined if changes in markers of SMC (MYLK, MYH11), ICC (KIT, 
ANO1), PDGFRα+ fibroblasts (PDGFRα, PDGFb), immune cells (MRC1, MHOX) and 
neurons (NOS1, SLC18A3) correlated with GCSI scores, or PAGI-SYM scores. This 
analysis revealed a significant correlation between the PAGI-SYM Fullness/Satiety 
subscores and expression levels of MYLK1, ANO1 and PDGFRα (Supplemental Table 2, 
with Spearman r values of −0.53, −0.55 and 0.54, respectively, Figure 6B). As our data 
revealed significant heterogeneity within the gastroparesis patient population we determined 
if this heterogeneity may be due to different groups of patients that could be identified based 
on their predominant symptoms (vomiting predominant, VP; dyspepsia predominant, DP; or 
regurgitation predominant, RP; Table 1). However, when we separated patients based on 
these predominant symptoms we did not observe any significant differences between the 
symptom groups (Figure 7).
Discussion
qRT-PCR analysis of RNA isolated from the muscularis layer of gastric biopsies obtained 
from patients with idiopathic gastroparesis and control subjects revealed changes in mRNAs 
that would indicate that idiopathic gastroparesis may be associated with changes in 
PDGFRα+ fibroblasts and SMCs rather than a loss of ICCs. These findings are in contrast to 
previously published immunohistological studies which showed decreased numbers of ICCs 
but no change in the number of PDGFRα+ fibroblasts in idiopathic gastroparesis subjects.
6, 12
 In the current study, we assessed both KIT and ANO1 as markers of ICCs. KIT is a 
receptor tyrosine kinase expressed on ICCs that is required for their survival. Antibodies to 
KIT were used in the previous immunohistological studies to quantitate ICC numbers.12 
ANO1 encodes a calcium regulated chloride channel that is specifically expressed in ICC 
and required for slow wave generation in the stomach.28 Previous studies have shown that 
ANO1 positive ICCs are also decreased in diabetic gastroparesis and this is associated with 
altered splicing of ANO1 resulting in the generation of an ANO1 transcript lacking exons 1 
and 2 that encodes a protein with altered channel activity.29 The qRT-PCR primers used in 
our study do not distinguish these two splice variants and thus represent total ANO1 mRNA 
levels. Although we did not observe any significant changes in either KIT or ANO1 mRNA 
expression in idiopathic gastroparesis patients compared to controls when we compared the 
relative expression of these two mRNAs in all samples we did observe a statistically 
significant correlation between the two, which would be expected as they are both markers 
of ICCs (Figure 2A). Consistent with the lack of changes in ICC markers we also did not 
observe any significant change in KITLG in the idiopathic gastroparesis patient samples 
(Figure 2A). However, we did observed a positive correlation between ANO1 and KITLG 
expression which would support a role of KITLG in maintaining ICCs. Similarly, we 
observed a strong correlation between PDGFRα and PDGFB mRNA levels across all 
samples (Figure 2B). This correlation between receptor and ligand may suggest that 
signaling through the PDGFRα receptor is required to maintain the intramuscular population 
of PDGFRα+ fibroblasts rather than both receptor and ligand being expressed by the same 
cells. This would be consistent with the known role of PDGFB in promoting cell 
proliferation.30, 31
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Analysis of mRNAs encoding SMC contractile proteins would suggest that there is not a 
generalized atrophy of SMCs in most patients with idiopathic gastroparesis but rather there 
are decreases in mRNAs encoding specific contractile and regulatory proteins (Figure 3). In 
particular we observed significant decreases in mRNAs encoding smooth muscle myosin 
heavy chain (MYH11), myosin light chain kinase (MYLK1) and p21 activated kinase 1 
(PAK1) (Figure 3). As myosin (MYH11) is required for smooth muscle contraction and 
phosphorylation of myosin light chain subunit by myosin light chain kinase (MYLK1) is 
required to stimulate myosin’s ATPase activity in response to contractile agonists, decreases 
in mRNAs encoding these proteins would be expected to directly impair contractility.32 
Similarly, PAK1 also phosphorylates myosin light chains, in addition to the myosin 
phosphatase targeting subunit MYPT1, to promote smooth muscle contractility. 33 Studies in 
mice have shown that decreased expression of Myh11, Mylk1 or PAK1 each individually 
result in impaired SMC contractility and GI motility.25, 32, 34 SRF- myocardin complexes 
regulate transcription of many smooth muscle contractile proteins including both MYH11 
and MYLK1. 25, 26, 35, 36 Although we did not observe a significant change in myocardin 
mRNA in samples from patients with idiopathic gastroparesis we did see a significant 
decrease in SRF mRNA (Figure 3). We also noted a tight correlation between levels of SRF 
and MYLK1 and MYH11 mRNAs (Figure 4), which would be consistent with previous 
studies that showed that expression of the MYLK1 gene is dependent on an SRF binding site 
in its first intron25 and that expression of MYH11 is also SRF-dependent.26 Unexpectedly, 
the decrease in SRF did not result in a significant attenuation of expression of other 
contractile proteins that are also SRF dependent. This may reflect differences in the 
sensitivity of each of the genes to levels of SRF.
Immunohistological studies have suggested that in diabetic gastroparesis a defect in M2 
macrophages may be contributing to the disease pathology.14, 37 Alternatively activated M2 
macrophages express high levels of heme oxygenase-1 and can thus protect against oxidative 
stress.38 Although our qRT-PCR analysis did not reveal an overall decrease in M2 
macrophages as determined by M2 selective markers MRC1 and CLEC7A we did observe a 
significant decrease in HMOX1 mRNA that encodes heme oxygenase-1 protein (Figure 5). 
This finding would suggest that similar to subjects with diabetic gastroparesis, subjects with 
idiopathic gastroparesis may also be more susceptible to oxidative damage. However, this 
does not appear to result in marked damage to neurons, to affect stomach motility, as mRNA 
encoding markers of both inhibitory and excitatory neurons were slightly elevated in 
gastroparesis patients (Figure 6A). The significance of the elevation in both inhibitory and 
excitatory neural markers is not immediately apparent, but could represent compensatory 
changes involving increased neural proliferation/ differentiation that have occurred as a 
consequence of the disease. This neural plasticity is consistent with the findings of a recent 
study showing that in adult mice, intestinal neurons are continually dying and being replaced 
with new neurons.39
Despite the numerous significant changes in mRNA expression that we observed in the 
stomach muscularis layer of patients with idiopathic gastroparesis, it is not clear how these 
changes relate to patient symptoms and underlying pathology. Although it is readily 
apparent how many of the changes could affect gastric motility we did not find significant 
correlations between individual mRNA expression and gastric emptying (Supplemental 
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Table 2), with the exception of KIT (Figure 6B). Changes in most markers of ICCs, 
PDGFRα+ fibroblasts, neurons, SMCs or immune cells did not correlate with 4 hour gastric 
retention values (Supplemental Table 2). The positive correlation we observed between KIT 
and gastric retention (Spearman r value of 0.745, Figure 6B) is rather puzzling, given that 
the gastroparesis patients as a group did not have significantly different levels of KIT 
expression compared to control subjects (Figure 2A). This positive correlation would 
suggest that higher KIT levels are associated with decreased gastric motility, which is 
contrary to the expected result.40, 41 There are a number of possible explanations for this 
observation. As we did not observe an overall decrease in KIT levels in gastroparesis 
patients compared to control subjects this statistical correlation between the small variations 
in KIT levels and gastric emptying may not be biologically meaningful. Alternatively, as we 
did not observe a similar correlation between ANO1 and gastric emptying, and both KIT and 
ANO1 are markers of ICC, this would suggest that gastric emptying is not correlating to ICC 
number but more specifically with KIT expression. One possible basis for this is that KIT is 
not exclusively expressed on ICC but is also expressed on several hematopoietic cells, 
including mast cells.42 The positive correlation between KIT expression and delayed gastric 
emptying could thus represent a correlation between increased numbers of mast cells as 
compared with ICC. We observed significant negative correlations between MYLK1 and 
ANO1 expression and the fullness/satiety PAGI-SYM subscore (Figure 6B). This suggests 
that these symptoms are associated with decreased SMC contractility and / or altered activity 
of ICCs. Conversely, PDGFRα receptor levels showed a significant, although weak, positive 
correlation with the fullness/satiety PAGI-SYM subscore (Figure 6B). This would suggest 
that the higher the PDGFRα receptor expression the worse the gastric emptying. This may 
reflect the role of PDGFRα+ fibroblasts in mediating inhibitory neural input to SMCs, 
which would be likely to attenuate contractility.
Despite being able to observe significant changes in mRNA expression between the 
gastroparesis and control subjects our data also revealed significant heterogeneity within the 
gastroparesis patient population. The different symptom predominant groups of patients do 
not seem to account for this heterogeneity (Figure 7). Our analyses identified several 
individual patients that had unique changes in mRNA expression which may provide insight 
into the specific pathophysiology of these patients. For example, one patient had markedly 
lower expression of ICC markers and had one of the lowest levels of KITLG expression, 
suggesting that ICC loss may be contributing to this patients pathology. In contrast, another 
patient had very low levels of expression of several contractile proteins which would be 
indicative of a more generalized SMC atrophy in this subject. These findings highlight the 
need for a more global analysis of the molecular changes that occur in the stomach of 
subjects with idiopathic gastroparesis in order to be able to design a more personalized 
rational therapeutic approach for each individual patient.
Although our qRT-PCR data suggest that idiopathic gastroparesis may be associated with 
changes in PDGFRα+ fibroblasts and SMCs rather than a loss of ICCs, this interpretation 
must be viewed within the limitations of our study. First, this conclusion is inferred from 
changes in mRNA expression rather than directly counting the cells themselves within the 
stomach muscularis. However, this may be both a weakness and a strength of our study as 
the muscle tissue from our biopsy samples is frozen and ground to a powder before isolation 
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of mRNA this generates a very homogeneous sample. To obtain similar homogeneity using 
immunohistology it is necessary to analyze a large number of sections taken from many 
different regions of the biopsy. Counting cells using immunohistology is also greatly 
affected by the orientation of the sections relative to the different muscle layers. The 
homogeneity of our sample does however, preclude us from determining in which muscle 
layer observed changes occur. A second limitation of our study is that the control patient 
population used in the study consisted of obese patients undergoing bariatric weight loss 
surgery. This raises the possibility that obesity itself may be affecting the cell populations or 
cell functions which could mask some of the effects of gastroparesis or could in itself be 
causing some of the changes we observed. Although this is a possibility, this is unlikely to 
explain why conclusions from our qRT-PCR analysis differ from those reported based on 
immunohistology, as these previous studies also used obese control subjects. 6, 12, 40 
Unfortunately it is not ethically feasible to obtain full thickness stomach biopsies from any 
other routinely available patient population, hence identifying possible obesity induced 
changes will await future studies in which a sufficiently large cohort of other control 
subjects are identified and analyzed. Finally it is important to note that as all of the 
gastroparesis patients we analyzed have well established disease it is not possible to 
determine if the alterations in mRNA expression are causal or a consequence of the disease.
In summary, the data described in this study provide the first detailed quantitative analysis of 
molecular changes that occur in the stomach of patients with idiopathic gastroparesis. 
Results from our studies suggest that changes in specific SMC contractile proteins may 
contribute to the dysmotility seen in idiopathic gastroparesis. Additional changes in numbers 
of PDGFRα+ fibroblasts may be further contributing to the dysmotility. The studies also 
highlight the potential of using molecular profiling to better identify the underlying 
pathology of individual gastroparesis patients which can then be used to design a more 
rational personalized therapeutic strategy.
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Key Points
• Idiopathic gastroparesis is a debilitating disease whose etiology is poorly 
defined. We aimed to identify transcriptional changes that may contribute to 
disease pathology.
• Smooth muscle tissue from idiopathic gastroparesis patients had decreased 
expression of mRNAs encoding several contractile and regulatory proteins, 
PDGFRα and its ligand PDGFB and Heme oxygenase 1. Conversely, there 
was no significant change in mRNAs characteristic of interstitial cells of Cajal 
(ICCs), such as KIT or ANO1.
• Our findings suggest that idiopathic gastroparesis is most commonly 
associated with transcriptional changes that are indicative of altered smooth 
muscle cells and PDGFRα+ fibroblast cells rather than ICCs.
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Figure 1. Separation of muscle, submucosa and mucosa layers from biopsies
Full thickness biopsies of stomach were obtained from two control subjects and the muscle, 
submucosa and mucosa, separated as described in ‘Methods’. RNA was isolated from each 
layer and the expression of mRNAs encoding proteins characteristic of each layer was 
quantitated by qRT-PCR. Expression levels relative to an internal control mRNA encoding 
TATA binding protein (TBP) are indicated. The mean±SEM of two samples are shown.
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Figure 2. qRT-PCR analysis of mRNA encoding proteins characteristic of ICCs and PDGFRα+ 
fibroblasts
Total RNA was isolated from the muscle layer of biopsies obtained from 14 control subjects 
and 16 subjects with idiopathic gastroparesis. qRT-PCR was used to measure the expression 
of each of the mRNAs indicated. Data presented were normalized to an internal control 
encoding TBP and are expressed relative to levels in the control subjects. Relative 
expression =2−ΔΔCt, where ΔΔCt = (CtGastroparesis-CtTBP) – (Ctcontrol-CtTBP). Each circle 
represents an individual subject with the control subjects represented as open circles and the 
gastroparesis subjects as closed circles. The mean±SEM are also indicated. Student T-tests 
were used to identify statistical significance. ns, not significant. Data from both control and 
gastroparesis subjects, were analyzed by spearman correlation and linear regression analyses 
to examine the relationship between expression of KIT, ANO1 and KITLG (A) and 
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PDGFRα and its ligands PDGFA and PDGFB (B). Plots of the linear regression analysis are 
shown together with the indicated Spearman r values and P values.
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Figure 3. qRT-PCR analysis of mRNA encoding proteins and transcription factors characteristic 
of contractile SMCs
Total RNA was isolated from the muscle layer of biopsies obtained from 14 control subjects 
and 16 subjects with idiopathic gastroparesis and analyzed by qRT-PCR as described in 
figure 2.
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Figure 4. Relationship between expression of contractile proteins and the transcription factors 
that regulate their expression
Data from both control and gastroparesis subjects, shown in figure 3, were analyzed by 
Spearman’s correlation and linear regression analyses to examine the relationship between 
expression of MYKL, MYH11 and transcription factors SRF and myocardin. These analyses 
revealed a highly significant positive correlation between the expression of SRF and 
MYLK1 and MYH11.
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Figure 5. qRT-PCR analysis of mRNA encoding proteins related to inflammation and 
macrophage polarity
Total RNA was isolated from the muscle layer of biopsies obtained from 14 control subjects 
and 16 subjects with idiopathic gastroparesis and analyzed by qRT-PCR as described in 
figure 2.
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Figure 6. qRT-PCR analysis of mRNA encoding proteins related to neurons and correlations 
between mRNA expression and clinical symptoms
A. Total RNA was isolated from the muscle layer of biopsies obtained from 14 control 
subjects and 16 subjects with idiopathic gastroparesis and analyzed by qRT-PCR as 
described in Figure 2. B. Linear regression analysis of the indicated mRNAs and PAGI-SYM 
subscores, or gastric retention, together with the Spearman r values and P values obtained 
from correlation analysis shown in Supplemental Table 2.
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Figure 7. qRT-PCR analysis of mRNA expression segregated based on symptom predominant 
phenotype
Graphs shown are replots of the mRNA expression data shown in Figures 2 and 3, in which 
the gastroparesis subjects were divided into those whose symptoms were vomiting 
predominant (VP), dyspepsia predominant (DP) or regurgitation predominant (RP) (Table 
1). A one way Anova, using a Kruskal-Wallis test with a Duns Multiple Comparison post-
test was performed to evaluate significant differences from control subjects and between 
gastroparesis groups. P values representing overall differences of the gastroparesis subjects 
from control subjects are shown, asterisks indicate individual groups that were significantly 
different from the controls, as determined by the Duns Multiple Comparison test. None of 
the gastroparesis groups were found to be significantly different from each other.
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Table 1
Clinical characteristics of patients with idiopathic gastroparesis
Idiopathic Gastroparesis (n=16)
Duration of symptoms 47.1±34.7 months
Gastroparesis severity
 Grade 3 16 (100%)
Symptoms presentation
 Vomiting-predominant 9 (56%)
 Dyspepsia-predominant 2 (12.5%)
 Regurgitation-predominant 5 (31%)
Weight loss >10% of body weight past 6 months 8 (50%)
Gastric emptying: % remaining at 4-hour* 29±19%
Gastric emptying: % remaining at 2-hour* 52±27%
PAGI-SYM Total Score* 3.0±0.8
PAGI-SYM Subscale Scores*
 Nausea/Vomiting 3.3±1.2
 Post prandial fullness/Early satiety 4.1±0.8
 Bloating 3.2±1.6
 Upper Abdominal Pain 3.1±1.6
 Lower Abdominal Pain 2.3±1.6
GCSI Total Score* 3.6±0.9
*
Mean±SD
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